Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $8.90 million. The enterprise value is -$45.22 million.

Market Cap	8.90M
Enterprise Value	-45.22M

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025, after market close.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

RLMD has 30.17 million shares outstanding. The number of shares has increased by 0.15% in one year.

Current Share Class	30.17M
Shares Outstanding	30.17M
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.73%
Owned by Institutions (%)	38.57%
Float	27.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.19
P/TBV Ratio	0.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.89

Current Ratio	6.89
Quick Ratio	6.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -116.60% and return on invested capital (ROIC) is -77.22%.

Return on Equity (ROE)	-116.60%
Return on Assets (ROA)	-69.48%
Return on Invested Capital (ROIC)	-77.22%
Return on Capital Employed (ROCE)	-192.38%
Revenue Per Employee	n/a
Profits Per Employee	-$4.32M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.05% in the last 52 weeks. The beta is 0.50, so RLMD's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-95.05%
50-Day Moving Average	0.38
200-Day Moving Average	2.49
Relative Strength Index (RSI)	30.80
Average Volume (20 Days)	2,063,446

Short Selling Information

The latest short interest is 838,002, so 2.78% of the outstanding shares have been sold short.

Short Interest	838,002
Short Previous Month	1.25M
Short % of Shares Out	2.78%
Short % of Float	3.04%
Short Ratio (days to cover)	1.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.64M
Pretax Income	-86.76M
Net Income	-86.49M
EBITDA	n/a
EBIT	-91.64M
Earnings Per Share (EPS)	-$2.87

Balance Sheet

Cash & Cash Equivalents	54.12M
Total Debt	n/a
Net Cash	54.12M
Net Cash Per Share	$1.79
Equity (Book Value)	47.63M
Book Value Per Share	1.58
Working Capital	47.62M

Cash Flow

Operating Cash Flow	-53.21M
Capital Expenditures	n/a
Free Cash Flow	-53.21M
FCF Per Share	-$1.76

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.15%
Shareholder Yield	-0.15%
Earnings Yield	-971.62%
FCF Yield	-597.73%

Analyst Forecast

The average price target for RLMD is $4.25, which is 1,340.68% higher than the current price. The consensus rating is "Hold".

Price Target	$4.25
Price Target Difference	1,340.68%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-23.80%

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Sep 30, 2019
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1